BRTX
BioRestorative Therapies, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.60
+3.90%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -1.02x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.00x
- Net debt / EBITDA
- 0.28x
Liquidity & coverage
- Current ratio
- 2.35x
- Quick ratio
- 2.35x
- Cash ratio
- 2.22x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $2.2M
Cash & dividend
- FCF / debt
- -344.71x
- Cash flow / debt
- -342.40x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026